Relevant to this, Marcato and Lee's groups have demonstrated that ALDH1A3-mediated modulation of RA-target genes contributes in vivo protumorigenic properties including the transcription of the MUC4 oncogene [20], to MDA-MB-231 breast cancer cells. The gene discussed is ALDH1A3; the disease is breast cancer.